Autoantibodies against oxidized LDL and endothelium-dependent vasodilation in insulin-dependent diabetes mellitus

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 115-122

  Mäkimattila, Sari ^a   Luoma, Jukka S ^b   Ylä Herttuala, Seppo ^b   Bergholm, Robert ^a   Utriainen, Tapio ^a   Virkamäki, Antti ^a   Mäntysaari, Matti ^c   Summanen, Paula ^a   Yki Järvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c CENTRAL MILITARY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Blood vessels; Glucose; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ALBUMIN; AUTOANTIBODY; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VESSEL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENDOTHELIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION; TURBIDIMETRY;

ADOLESCENT; ADULT; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FOREARM; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REGIONAL BLOOD FLOW; VASODILATION;

EID: 0344980405     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00180-X     Document Type: Article

References (51)

1. Ludmer P.L., Selwyn A.P., Shook T.L. et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
2. Chowienczyk P.J., Watts G.F., Cockcroft J.R., Ritter J.M. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1992;1430-1432.
3. Creager M.A., Cooke J.P., Mendelsohn M.E. et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 86:1990;228-234.
4. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 88:1993;2541-2547.
5. Drexler H., Zeiher A.M., Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1991;1546-1550.
6. Heitzer T., Ylä-Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 93:1996;1346-1353.
7. Palinski W., Rosenfeld M.E., Ylä-Herttuala S. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
8. Salonen J.T., Ylä-Herttuala S., Yamamoto R. et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
9. Maggi E., Perani G., Falaschi F. et al. Autoantibodies against oxidized low-density lipoproteins in patients with coronary atherosclerosis. Presse Med. 23:1994;1158-1162.
10. Bellomo G., Maggi E., Poli M., Agosta F.G., Bollati P., Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
11. Pyörälä K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 3:1987;463-524.
12. Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 90:1992;2548-2554.
13. Elliott T.G., Cockcroft J.R., Groop P.-H., Viberti G.C., Ritter J.M. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci. 85:1993;687-693.
14. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Craeger M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
15. Halkin A., Benjamin N., Doktor H.S., Todd S.D., Viberti G.C., Ritter J.M. Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci. 81:1991;223-232.
16. Smits P., Kapma J.-A., Jacobs M.-C., Lutterman J., Thien T. Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes. 42:1993;148-153.
17. MacAllister R.J., Calver A.L., Collier J., Edwards C.M.B., Herreros B. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci. 89:1995;183-190.
18. 2-. Diabetes Metab Rev. 14:1988;25-30.
19. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J. 245:1987;243-250.
20. Hunt J.V., Smith C.C.T., Wolff S.P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 39:1990;1420-1424.
21. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 173:1990;932-939.
22. Tesfamariam B., Brown M.L., Deykin D., Cohen R.A. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 85:1990;929-932.
23. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest. 93:1994;998-1004.
24. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 250:1986;H822-H827.
25. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
26. Heinecke J.W., Baker L., Rosen H., Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 77:1986;757-761.
27. Hiramatsu K., Rosen H., Heinecke J.W., Wolfbauer G., Chait A. Superoxide initiates oxidation of low density lipoproteins by human monocytes. Arteriosclerosis. 7:1986;55-60.
28. Mäkimattila S., Mäntysaari M., Groop P.-H. et al. Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in IDDM. Circulation. 95:1997;618-625.
29. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification: ETDRS Report No.10. Ophthalmology. 98:1991;786-806.
30. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey methods. 2nd ed WHO monograph series. 56:1982;123-143 Geneva, WHO.
31. Groop P.-H., Elliott T., Ekstrand A. et al. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes. 45:1996;974-979.
32. Uusitupa M.I.J., Niskanen L., Luoma J. et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;1236-1242.
33. Tesfamariam B., Brown M.L., Cohen R.A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest. 87:1991;1643-1648.
34. Desbuquois B., Aurbach G.D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab. 33:1971;732-738.
35. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915-924.
36. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Biol Med. 6:1989;67-75.
37. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A.Y., Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 30:1989;627-630.
38. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
39. Puurunen M., Mänttäri M., Manninen V. et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med. 154:1994;2605-2609.
40. Ylä-Herttuala S. Is oxidized low-density lipoprotein present in vivo? Curr Opin Lipidol. 9:1998;337-344.
41. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest. 94:1994;771-778.
42. Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 43:1994;1010-1014.
43. Gallou G., Ruelland A., Legras B., Maugendre D., Allannic H., Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta. 214:1993;227-234.
44. O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest. 100:1997;678-684.
45. Chowienczyk P.J., Cockcroft J.R., Ritter J.M. Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci. 87:1994;45-51.
46. Thornalley P.J., Stern A. The production of free radicals during the autoxidation of monosaccharides by buffer ions. Carbohydr Res. 134:1984;191-204.
47. Jessup W. Oxidized lipoproteins and nitric oxide. Curr Opin Lipidol. 7:1996;274-280.
48. Beckman J.S., Ye Y.Z., Anderson P.G. et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 375:1994;81-88.
49. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 263:1992;H321-H326.
50. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267.
51. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.